Michael D Olson1, Kevin M Miller. 1. Jules Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, 100 Stein Plaza, Los Angeles, CA 90095, USA.
Abstract
PURPOSE: To describe the color vision disturbance reported by patients in whom a clear intraocular lens (IOL) was implanted in one eye and a yellow-tinted (blue-light-absorbing) IOL in the other eye. DESIGN: Retrospective interventional case series. METHODS: Data recorded included demographic information, dates of surgery, IOL model and power (manufacturer is the same for all lenses), best-corrected visual acuity, and subjective visual complaints. RESULTS: Four of five patients had no spontaneous color vision complaints. When these patients were informed of the unintended mismatch, all remarked that they could perceive a color vision difference, but that it was not bothersome. One of the five patients reported "beige" vision. None of the patients wanted an IOL exchange. CONCLUSION: Many patients can tolerate the color vision imbalance that results when a clear IOL is implanted in one eye and a yellow-tinted IOL is implanted in the other eye.
PURPOSE: To describe the color vision disturbance reported by patients in whom a clear intraocular lens (IOL) was implanted in one eye and a yellow-tinted (blue-light-absorbing) IOL in the other eye. DESIGN: Retrospective interventional case series. METHODS: Data recorded included demographic information, dates of surgery, IOL model and power (manufacturer is the same for all lenses), best-corrected visual acuity, and subjective visual complaints. RESULTS: Four of five patients had no spontaneous color vision complaints. When these patients were informed of the unintended mismatch, all remarked that they could perceive a color vision difference, but that it was not bothersome. One of the five patients reported "beige" vision. None of the patients wanted an IOL exchange. CONCLUSION: Many patients can tolerate the color vision imbalance that results when a clear IOL is implanted in one eye and a yellow-tinted IOL is implanted in the other eye.
Authors: Vivienne C Greenstein; Flavia Chiosi; Paul Baker; William Seiple; Karen Holopigian; Richard E Braunstein; Janet R Sparrow Journal: J Cataract Refract Surg Date: 2007-04 Impact factor: 3.351